1. Home
  2. NPWR vs EQ Comparison

NPWR vs EQ Comparison

Compare NPWR & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NET Power Inc.

NPWR

NET Power Inc.

HOLD

Current Price

$1.70

Market Cap

137.0M

Sector

Energy

ML Signal

HOLD

Logo Equillium Inc.

EQ

Equillium Inc.

HOLD

Current Price

$2.31

Market Cap

157.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPWR
EQ
Founded
2010
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
137.0M
157.4M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
NPWR
EQ
Price
$1.70
$2.31
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$3.50
$8.00
AVG Volume (30 Days)
743.5K
477.7K
Earning Date
05-11-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$41,095,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.35
$0.76
52 Week High
$5.20
$3.54

Technical Indicators

Market Signals
Indicator
NPWR
EQ
Relative Strength Index (RSI) 55.43 47.48
Support Level $1.63 $1.97
Resistance Level $1.84 $2.61
Average True Range (ATR) 0.14 0.19
MACD 0.02 0.03
Stochastic Oscillator 40.16 59.32

Price Performance

Historical Comparison
NPWR
EQ

About NPWR NET Power Inc.

NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. Its business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. The company has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: